Jump to main navigation | Jump to sub navigation | Jump to SiteMap | Jump to Home Page |
| Oncology |
| Inflammatory Bowel Disease |
| Oncology Supportive Care (Mucositis) |
| Dermatology |
| Histology and Molecular Services |
| Scientific Overview |
| Discovery Platform |
| Emerging Protein Therapeutic Pipeline |
| Partnerships |
| Biomarkers for Drug Development |
| Partnerships |
| Oncology Biomarker Models |
| Investor Information |
| Company Profile |
| Shareholder Information |
| Share Price Information |
| RNS Announcements |
| Directors |
| Company Reports |
| Constitutional Documents |
| Corporate Governance |
| Advisors |
| How to find us |
Epistem draws on its considerable expertise in the epithelial biology field to provide a range of specialist skin research services for healthcare, cosmetic and pharmaceutical product development.
Epistem also specialises in analysing (IHC, ELISA and gene expression) a range of skin markers (involucrin, filaggrin etc.) on skin biopsies from 'claim support' human trials.
Epistem has access to a variety of human skin types and offers expertise and services in the following areas:
|
|
|